InvestorsHub Logo
Followers 8
Posts 665
Boards Moderated 0
Alias Born 05/09/2015

Re: Investor_cmz post# 30416

Friday, 09/04/2020 3:00:13 AM

Friday, September 04, 2020 3:00:13 AM

Post# of 34573
Hmmmmm.... merger ? Co-use of new manufacturing facility...


ViraCyte gets IP from Baylor; deal expanded to address coronavirus pandemic
Executive Summary

Baylor College of Medicine licensed ViraCyte LLC exclusive global rights (including rights to sublicense) to intellectual property associated with virus-specific T-cell immunotherapies aimed at preventing and/or treating viral infections.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News